Literature DB >> 29373866

An intermediate cell state allows rerouting of cell fate.

Xiukun Wang1,2, Jinsong Li3,2,4.   

Abstract

Somatic cell reprogramming into pluripotent stem cells using transcriptional factors or chemical compounds has been shown to include an intermediate cell state with epithelial features. Two recent papers show that this intermediate state can be redirected to create other differentiated cell types-specifically hepatocytes and neurons-using chemical cocktails. These results shed new light on a critical intermediate in cell fate conversion with mechanistic and practical implications.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Mesh:

Year:  2017        PMID: 29373866      PMCID: PMC5704494          DOI: 10.1074/jbc.H117.812537

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming.

Authors:  Payman Samavarchi-Tehrani; Azadeh Golipour; Laurent David; Hoon-Ki Sung; Tobias A Beyer; Alessandro Datti; Knut Woltjen; Andras Nagy; Jeffrey L Wrana
Journal:  Cell Stem Cell       Date:  2010-06-17       Impact factor: 24.633

2.  When fibroblasts MET iPSCs.

Authors:  Jose M Polo; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2010-06-17       Impact factor: 24.633

3.  A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts.

Authors:  Ronghui Li; Jialiang Liang; Su Ni; Ting Zhou; Xiaobing Qing; Huapeng Li; Wenzhi He; Jiekai Chen; Feng Li; Qiang Zhuang; Baoming Qin; Jianyong Xu; Wen Li; Jiayin Yang; Yi Gan; Dajiang Qin; Shipeng Feng; Hong Song; Dongshan Yang; Biliang Zhang; Lingwen Zeng; Liangxue Lai; Miguel Angel Esteban; Duanqing Pei
Journal:  Cell Stem Cell       Date:  2010-06-17       Impact factor: 24.633

4.  A XEN-like State Bridges Somatic Cells to Pluripotency during Chemical Reprogramming.

Authors:  Yang Zhao; Ting Zhao; Jingyang Guan; Xu Zhang; Yao Fu; Junqing Ye; Jialiang Zhu; Gaofan Meng; Jian Ge; Susu Yang; Lin Cheng; Yaqin Du; Chaoran Zhao; Ting Wang; Linlin Su; Weifeng Yang; Hongkui Deng
Journal:  Cell       Date:  2015-12-10       Impact factor: 41.582

Review 5.  Molecular features of cellular reprogramming and development.

Authors:  Zachary D Smith; Camille Sindhu; Alexander Meissner
Journal:  Nat Rev Mol Cell Biol       Date:  2016-02-17       Impact factor: 94.444

Review 6.  Chemical reprogramming and transdifferentiation.

Authors:  Xin Xie; Yanbin Fu; Jian Liu
Journal:  Curr Opin Genet Dev       Date:  2017-07-26       Impact factor: 5.578

7.  Direct Reprogramming of Fibroblasts via a Chemically Induced XEN-like State.

Authors:  Xiang Li; Defang Liu; Yantao Ma; Xiaomin Du; Junzhan Jing; Lipeng Wang; Bingqing Xie; Da Sun; Shaoqiang Sun; Xueqin Jin; Xu Zhang; Ting Zhao; Jingyang Guan; Zexuan Yi; Weifeng Lai; Ping Zheng; Zhuo Huang; Yanzhong Chang; Zhen Chai; Jun Xu; Hongkui Deng
Journal:  Cell Stem Cell       Date:  2017-06-22       Impact factor: 24.633

Review 8.  Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity.

Authors:  Nicolas Skrypek; Steven Goossens; Eva De Smedt; Niels Vandamme; Geert Berx
Journal:  Trends Genet       Date:  2017-09-14       Impact factor: 11.639

9.  Chemical reprogramming of mouse embryonic and adult fibroblast into endoderm lineage.

Authors:  Shangtao Cao; Shengyong Yu; Yan Chen; Xiaoshan Wang; Chunhua Zhou; Yuting Liu; Junqi Kuang; He Liu; Dongwei Li; Jing Ye; Yue Qin; Shilong Chu; Linlin Wu; Lin Guo; Yinxiong Li; Xiaodong Shu; Jiekai Chen; Jing Liu; Duanqing Pei
Journal:  J Biol Chem       Date:  2017-09-21       Impact factor: 5.157

  9 in total
  1 in total

1.  An enriched network motif family regulates multistep cell fate transitions with restricted reversibility.

Authors:  Yujie Ye; Xin Kang; Jordan Bailey; Chunhe Li; Tian Hong
Journal:  PLoS Comput Biol       Date:  2019-03-07       Impact factor: 4.475

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.